# This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

> **NCT03629054** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
- **DRUG:** Empagliflozin
- **DRUG:** Linagliptin
- **DRUG:** Metformin HCl

## Key facts

- **NCT ID:** NCT03629054
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-27
- **Primary completion:** 2018-11-05
- **Final completion:** 2018-11-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03629054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03629054, "This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03629054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*